Sun Yifeng, Gu Chang, Shi Jianxin, Fang Wentao, Luo Qingquan, Hu Dingzhong, Fu Shijie, Pan Xufeng, Chen Yong, Yang Yu, Yang Haitang, Zhao Heng, Chen Haiquan
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
J Thorac Dis. 2017 Mar;9(3):725-733. doi: 10.21037/jtd.2017.03.03.
Discuss an appropriate strategy for treatment of invasive thymoma invading adjacent great vessels.
A retrospective study on 25 patients with invasive thymoma invading neighboring great vessels was performed. The corresponding data including clinical presentation, operation procedure, adjuvant radio-chemotherapy and follow-up were reviewed.
Twenty of 25 (80%) patients with invasive thymoma underwent complete resection of the tumor along with vessel reconstruction. Intraoperatively, different types of operation were conducted, namely, brachiocephalic vein (BCV)-right atrial appendage (RAA) reconstruction in 11 cases, complex vessel reconstruction (more than one graft) in 1 case and superior vena cava (SVC)-SVC reconstruction in the remaining cases. Ringed polytetrafluoroethylene (PTFE) grafts were used for vessel reconstruction. Postoperatively, three cases suffered from pulmonary infection, and three cases had haemothorax, chylothorax and atelectasis, respectively. Two patients died due to acute respiratory distress syndrome within 90 days after the surgery. Within the remaining patients, 11 cases (44%) experienced a relapse and finally 8 (32%) patients died. Compared to R1 resection group, R0 resection group had a better prognosis (Log-rank P=0.0196). The 3- and 5-year survival rates were 79.6% and 59.1%, with median survival time of 84 months.
Reconstruction of mediastinal vessels for invasive thymoma is a feasible technology method. Radical resection of the tumor with involved neighboring structures is the key to prolong overall survival for patients suffered from invasive thymoma.
探讨侵袭性胸腺瘤侵犯相邻大血管的合适治疗策略。
对25例侵袭性胸腺瘤侵犯相邻大血管的患者进行回顾性研究。回顾了包括临床表现、手术过程、辅助放化疗及随访等相应数据。
25例侵袭性胸腺瘤患者中有20例(80%)接受了肿瘤完整切除及血管重建。术中进行了不同类型的手术,即11例头臂静脉(BCV)-右心耳(RAA)重建,1例复杂血管重建(多个移植物),其余病例为上腔静脉(SVC)-SVC重建。血管重建使用了带环聚四氟乙烯(PTFE)移植物。术后,3例发生肺部感染,3例分别出现血胸、乳糜胸和肺不张。2例患者在术后90天内死于急性呼吸窘迫综合征。其余患者中,11例(44%)复发,最终8例(32%)患者死亡。与R1切除组相比,R0切除组预后更好(对数秩检验P = 0.0196)。3年和5年生存率分别为79.6%和59.1%,中位生存时间为84个月。
侵袭性胸腺瘤的纵隔血管重建是一种可行的技术方法。彻底切除累及相邻结构的肿瘤是延长侵袭性胸腺瘤患者总生存期的关键。